Visit https://www.peervoice.com/EMZ860 to view the entire programme with slides. After completing “Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making”, participants will be able to: Evaluate current efficacy and safety data related to the use of targeted therapies in the treatment of advanced or metastatic biliary tract cancer (BTC); Apply best practices and guideline recommendations for timely molecular testing of BTC; and Design personalised treatment regimens for individual patients with BTC based on current evidence and guidelines.